Literature DB >> 7160417

Cimetidine dosage regimen for patients with renal failure and for geriatric patients.

W A Ritschel.   

Abstract

Using a recently developed computer program based on a correlation between methods to predict the elimination half-life and apparent volume of distribution of cimetidine and actual data from patients, ideal dosage regimens were generated for patients with renal impairment and for geriatric patients, together with the corresponding maximum and minimum steady state concentrations. Using the ideal dosage regimens, practical regimens with feasible dosing intervals of 6, 8 and 12 h were computed, which should result in therapeutic concentrations of 0.4 to 1.3 micrograms/ml. For uraemic patients and geriatric patients above the age of 75 years it would be desirable to have an additional oral 100 mg dosage form.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160417     DOI: 10.1007/bf00637496

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  The pathologic physiology of chronic Bright's disease. An exposition of the "intact nephron hypothesis".

Authors:  N S BRICKER; P A MORRIN; S W KIME
Journal:  Am J Med       Date:  1960-01       Impact factor: 4.965

2.  Pharmacokinetic approach to drug dosing in the aged.

Authors:  W A Ritschel
Journal:  J Am Geriatr Soc       Date:  1976-08       Impact factor: 5.562

3.  Oral absorption of cimetidine and its clearance in patients with renal failure.

Authors:  R Larsson; G Bodemar; B Norlander
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

4.  Cimetidine and mental confusion.

Authors:  J C Delaney; M Ravey
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

5.  Cimetidine and renal failure.

Authors:  W Grave; J N Nadorp; J J Rutten
Journal:  Lancet       Date:  1977-10-01       Impact factor: 79.321

6.  Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients.

Authors:  A Somogyi; H G Rohner; R Gugler
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

7.  Blood level of cimetidine in relation to age.

Authors:  A Redolfi; E Borgogelli; E Lodola
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

8.  Cimetidine and mental confusion.

Authors:  M A McMillen; D Ambis; J H Siegel
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

9.  Age and renal clearance of cimetidine.

Authors:  D E Drayer; J Romankiewicz; B Lorenzo; M M Reidenberg
Journal:  Clin Pharmacol Ther       Date:  1982-01       Impact factor: 6.875

10.  Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion.

Authors:  J J Schentag; F B Cerra; G Calleri; E DeGlopper; J Q Rose; H Bernhard
Journal:  Lancet       Date:  1979-01-27       Impact factor: 79.321

View more
  5 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Treatment of peptic ulcer in the elderly. Proton pump inhibitors and histamine H2 receptor antagonists.

Authors:  M Lazzaroni; G Bianchi Porro
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

Review 3.  Identification of populations at risk in drug testing and therapy: application to elderly patients.

Authors:  W A Ritschel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Jan-Mar       Impact factor: 2.441

Review 4.  Prescribing policy for antiulcer treatment in the elderly.

Authors:  G Bianchi Porro; M Lazzaroni
Journal:  Drugs Aging       Date:  1993 Jul-Aug       Impact factor: 3.923

Review 5.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.